Latest filing published 01 Dec 2022 for Applied Genetic Technologies CORP.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Stephen W. Potter, listed as senior executive, appears in our data through filings on Applied Genetic Technologies Corp shares, published by SEC (Form 4). Over a trading history stretching from 16 September 2016 to 30 November 2022, the count stands at 9 filings.
The open-market side counts 2 purchases for €11k alongside 1 sale for €5,965. Taken together, the purchases exceed the sales by €5,127. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 4 share grants. So far in 2022, the count stands at no purchases and 1 sale.
The newest entry dates from 1 December 2022: a transaction, in Applied Genetic Technologies Corp. The latest purchase dates back some time: it was published 3,678 days ago, on 27 September 2016. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations